These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3038709)

  • 41. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids.
    Bader R; Mannucci PM; Tripodi A; Hirsh J; Keller F; Solleder EM; Hawkins P; Peng M; Pelzer H; Teijidor LM
    Thromb Haemost; 1994 Mar; 71(3):292-9. PubMed ID: 8029792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma hypercoagulability in the presence of thrombomodulin but not of activated protein C in patients with cirrhosis.
    Lebreton A; Sinegre T; Pereira B; Lamblin G; Duron C; Abergel A
    J Gastroenterol Hepatol; 2017 Apr; 32(4):916-924. PubMed ID: 27421039
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va.
    Nishioka J; Ido M; Hayashi T; Suzuki K
    Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A.
    Dielis AW; Balliël WM; van Oerle R; Hermens WT; Spronk HM; Ten Cate H; Hamulyák K
    Haematologica; 2008 Sep; 93(9):1351-7. PubMed ID: 18641016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Procoagulant imbalance in patients with non-alcoholic fatty liver disease.
    Tripodi A; Fracanzani AL; Primignani M; Chantarangkul V; Clerici M; Mannucci PM; Peyvandi F; Bertelli C; Valenti L; Fargion S
    J Hepatol; 2014 Jul; 61(1):148-54. PubMed ID: 24657400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Obtaining active extracts for use in production of soluble thromboplastin].
    Tarasova LN; Repniakova EM; Vladimirova SG; Savinykh EIu
    Klin Lab Diagn; 2004 Jul; (7):21-4. PubMed ID: 15372881
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
    Valdes-Camin R; Callahan JB; Ebert RF
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboplastin-thrombomodulin-mediated time: a new global test sensitive to protein S deficiency and increased levels of factors II, V, VII and X.
    Borrell M; Llobet D; Ortín R; Felices R; Vallvé C; Mateo J; Souto J; Fontcuberta J
    Haematologica; 2002 Apr; 87(4):415-9. PubMed ID: 11940486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lupus anticoagulant--antiphospholipid antibodies and thrombophilia. Relation to protein C--protein S--thrombomodulin.
    Tsakiris DA; Settas L; Makris PE; Marbet GA
    J Rheumatol; 1990 Jun; 17(6):785-9. PubMed ID: 2167370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purification of glycosylated apoprotein of tissue factor from human brain and inhibition of its procoagulant activity by a specific antibody.
    Tanaka H; Janssen B; Preissner KT; Müller-Berghaus G
    Thromb Res; 1985 Dec; 40(6):745-56. PubMed ID: 3937286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thromboplastic activity of acetone-dehydrated chicken brain powder extracts after repeated extraction and dilution.
    Shum YS; Griminger P
    Poult Sci; 1972 Mar; 51(2):402-7. PubMed ID: 4643113
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on the differences in activity of lung and brain thromboplastin.
    WEISS HJ; EICHELBERGER JW; CROSBY WH
    J Clin Invest; 1961 Feb; 40(2):205-14. PubMed ID: 13784066
    [No Abstract]   [Full Text] [Related]  

  • 53. Partial purification of a native form of thromboplastin from porcine brain [proceedings].
    Gardiner JE; Howell RM
    Biochem Soc Trans; 1980 Feb; 8(1):133. PubMed ID: 7371920
    [No Abstract]   [Full Text] [Related]  

  • 54. [On the importance of concentration and activity of tissue thromboplastin].
    PUDLAK P
    Cas Lek Cesk; 1961 Nov; 100():1409-13. PubMed ID: 14489124
    [No Abstract]   [Full Text] [Related]  

  • 55. [PRODUCTION OF THROMBOPLASTIN FROM LYOPHILIZED BRAIN TISSUE].
    ULIANOVA ND
    Lab Delo; 1964; 10():615-6. PubMed ID: 14295009
    [No Abstract]   [Full Text] [Related]  

  • 56. [Supplementary observations on the antagonism between lipid extracts of bovine brain and plasma thromboplastin].
    KAHN M; BOURGAIN R
    Arch Int Pharmacodyn Ther; 1962 Jul; 138():345-7. PubMed ID: 14453115
    [No Abstract]   [Full Text] [Related]  

  • 57. The thrombin-inhibitory effect of certain thromboplastin preparations.
    HARTMANN RC
    Am J Med Sci; 1951 Sep; 222(3):279-84. PubMed ID: 14877814
    [No Abstract]   [Full Text] [Related]  

  • 58. The active principle of placental toxin; thromboplastin; its inactivator in blood; antithromboplastin.
    SCHNEIDER CL
    Am J Physiol; 1947 Apr; 149(1):123-9. PubMed ID: 20291955
    [No Abstract]   [Full Text] [Related]  

  • 59. Nature of the refractory state following sublethal dose of human placental thromboplastin.
    FULTON LD; PAGE EW
    Proc Soc Exp Biol Med; 1948; 68(3):594-6. PubMed ID: 18884301
    [No Abstract]   [Full Text] [Related]  

  • 60. Maestro tissue factor reaches new hEIGHT.
    Pryzdial ELG
    Blood; 2017 Oct; 130(14):1604-1605. PubMed ID: 28983017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.